ES8202059A1 - Un metodo de preparacion de antigeno superficial de la hepa-titis b - Google Patents

Un metodo de preparacion de antigeno superficial de la hepa-titis b

Info

Publication number
ES8202059A1
ES8202059A1 ES496445A ES496445A ES8202059A1 ES 8202059 A1 ES8202059 A1 ES 8202059A1 ES 496445 A ES496445 A ES 496445A ES 496445 A ES496445 A ES 496445A ES 8202059 A1 ES8202059 A1 ES 8202059A1
Authority
ES
Spain
Prior art keywords
surface antigen
hepatitis
phase
antigen
preparing hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES496445A
Other languages
English (en)
Spanish (es)
Other versions
ES496445A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES496445A0 publication Critical patent/ES496445A0/es
Publication of ES8202059A1 publication Critical patent/ES8202059A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ES496445A 1979-11-02 1980-10-31 Un metodo de preparacion de antigeno superficial de la hepa-titis b Expired ES8202059A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/090,169 US4301250A (en) 1979-11-02 1979-11-02 Method of producing hepatitis B surface antigen

Publications (2)

Publication Number Publication Date
ES496445A0 ES496445A0 (es) 1982-01-16
ES8202059A1 true ES8202059A1 (es) 1982-01-16

Family

ID=22221612

Family Applications (1)

Application Number Title Priority Date Filing Date
ES496445A Expired ES8202059A1 (es) 1979-11-02 1980-10-31 Un metodo de preparacion de antigeno superficial de la hepa-titis b

Country Status (10)

Country Link
US (1) US4301250A (enExample)
EP (1) EP0028567B1 (enExample)
JP (1) JPS5679625A (enExample)
AT (1) ATE10806T1 (enExample)
DE (1) DE3069846D1 (enExample)
DK (1) DK462280A (enExample)
ES (1) ES8202059A1 (enExample)
GR (1) GR70783B (enExample)
IE (1) IE50695B1 (enExample)
PT (1) PT71977B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51173B1 (en) * 1980-03-27 1986-10-29 Merck & Co Inc Method of growing hepatitis b surface antigen
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US4301249A (en) * 1980-07-23 1981-11-17 Merck & Co., Inc. High titer production of hepatitis A virus
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4714613A (en) * 1982-09-30 1987-12-22 The Albert Einstein College Of Medicine Of Yeshiva University Method of suppressing cell growth by immunotherapy
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
BRPI0811533A2 (pt) * 2007-05-04 2014-10-14 Baxter Int Método para a produção de um vírus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
JPS4940925A (enExample) * 1972-08-26 1974-04-17
JPS5531762B2 (enExample) * 1973-03-28 1980-08-20
JPS5127730A (enExample) * 1974-08-31 1976-03-08 Tokyo Shibaura Electric Co
JPS5822008B2 (ja) * 1975-08-07 1983-05-06 デユフアル・インテルナチオナル・レセ−ルフ・ベ−・ヴエ− 猫のヘルペスウイルスのワクチン
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Also Published As

Publication number Publication date
ATE10806T1 (de) 1985-01-15
EP0028567A3 (en) 1982-05-26
US4301250A (en) 1981-11-17
GR70783B (enExample) 1983-03-23
ES496445A0 (es) 1982-01-16
IE50695B1 (en) 1986-06-25
JPS5679625A (en) 1981-06-30
EP0028567B1 (en) 1984-12-19
EP0028567A2 (en) 1981-05-13
IE802262L (en) 1981-05-02
PT71977B (en) 1982-03-31
PT71977A (en) 1980-11-01
JPH0156051B2 (enExample) 1989-11-28
DK462280A (da) 1981-05-03
DE3069846D1 (en) 1985-01-31

Similar Documents

Publication Publication Date Title
IT1132101B (it) Procedimento per la produzione di etanolo in forte concentrazione impiegando microorganismi immobilizzati
NL179923C (nl) Werkwijze voor het kweken of instandhouden van cellen in vitro.
ES2055048T3 (es) Liofilizacion de eritrocitos y medios para usarse en ella.
ATE482267T1 (de) Tierzellen und verfahren für die replikation von influenza viren
ES2102984T3 (es) Medios para el crecimiento de celulas y procedimiento para preparar los mismos.
IL98182A0 (en) Cell compositions and methods for the preparation thereof
DK13580A (da) Fremgangsmaade til forbedring af oploeseligheden af biologisk aktive stoffer i vand og lavere aliphatiske alkoholer samt saaledes fremstillede forbindelser med forbedret oploeselighed
IT1207525B (it) Metodo per la preservazione difogli trapiantabili di epitelio coltivato in vitro vitale.
FR2322199A1 (fr) Milieu de culture et procede pour la preparation de ferments pour fromages
NO165598C (no) Fremgangsmaate for ekspresjon av hepatitt b overflateantigen i cellekultur samt ekspresjonsvektor.
ES8300473A1 (es) Un metodo de preparacion del antigeno superficial de la hepatitis b.
AR220972A1 (es) Metodo mejorado para fabricar una membrana de fibra hueca anisotropica y la membrana producida
GT197854594A (es) Vacuna contra haemophilus influenzae
ATE15693T1 (de) Zellkultur-verfahren.
AR220838A1 (es) Procedimiento para preparar una vacuna de virus de influenza(gripe);procedimiento de propagacion de virus de influenza y cultivo liquido de celulas inoculadas con dicho virus,de aplicacion exclusiva en dicho procedimiento para preparar dicha vacuna
IT7922818A0 (it) Procedimento per mantenere attiva la cultura di fermenti.
DE60111490D1 (de) Herstellung von vakzinen unter der verwendung von hybrid-zellen
ES2043884T3 (es) Metodo de gran rendimiento para la preparacion de algodon a partir de celulas cultivadas.
SE8205247D0 (sv) Fiskvacciner
SE8201128L (sv) Forfarande for reproduktion av virulent treponema pallidum i vevnadsk ultur
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
AT306051B (de) Verfahren zur Herstellung von lagerungsbeständigem reduziertem Nikotinamid-adenin-dinucleotid NADH
GB1486557A (en) Process for the preparation of pyrogen-free sub-unit vaccine
JPS51125787A (en) Method for cultivating and processing of mashrooms
DK130424B (da) Fremgangsmåde til fremstilling af glucoseisomerase samt dyrkningsmedium til brug ved fremgangsmåden.